What is Coronavirus?
 |
| Covid - 19 |
The virus that causes COVID-19 is mainly transmitted through droplets generated when an infected person coughs, sneezes, or exhales. These droplets are too heavy to hang in the air, and quickly fall on floors or surfaces.
You can be infected by breathing in the virus if you are within close proximity of someone who has COVID-19, or by touching a contaminated surface and then your eyes, nose or mouth.
How to earn pocket money and mobile recharge per day 300 to 500 By Google task mate App
Most common symptoms:
● fever
● dry cough
● tiredness
● Less common symptoms:
● aches and pains
● sore throat
● diarrhoea
● conjunctivitis
● headache
● loss of taste or smell
a rash on skin, or discolouration of fingers or toes
Serious symptoms:
difficulty breathing or shortness of breath
chest pain or pressure
Total Coronavirus Updates India And Bihar
Totals in Bihar
Total cases
241K
+650
Recovered
234K
+617
Deaths
1,312
+5
Totals in India
Total cases
9.83M
+30,031
Recovered
9.32M
+33,519
Deaths
143K
+443
Where are we in the Covid-19 vaccine race?
Coronavirus vaccine: Here's what we know about the race to deliver vaccines to help end the Covid-19 pandemic that has killed 1.59 million people worldwide.
A sign directs healthcare workers to a rehearsal for the administration of the Pfizer coronavirus disease (COVID-19) vaccine at Indiana University Health in Indianapolis, Indiana, US, December 11, 2020. (Reuters Photo: Bryan Woolston)
Pfizer Inc and BioNTech SE received US regulatory authorization for their COVID-19 vaccine on Friday, making it the first inoculation against the new coronavirus to get a regulatory green light in the United States.
The following is what we know about the race to deliver vaccines to help end the coronavirus pandemic that has killed 1.59 million people worldwide:
Coronavirus vaccine: Who is furthest along?
US drugmaker Pfizer and German partner BioNTech are the coronavirus vaccine trailblazers. On Nov. 18, they became the first in the world to release full late-stage trial data. Britain was the first to approve the shot for emergency use on Dec. 3, followed by Canada on Dec. 9 and the US Food and Drug Administration (FDA) on Dec. 11.
The European Medicines Agency (EMA) is due to complete its review of the shot by Dec. 29 and India is accelerating its review.
Australia Ends COVID-19 Vaccine Trials Due To HIV Antibody Positives
Following consultation with the Australian Government, UQ and CSL decided not to progress the vaccine candidate to phase 2 and 3 clinical trials.
The vaccine was one of four candidates that Australia had committed to buy (Representational)
Melbourne:
Australia on Friday stopped the further development of a COVID-19 vaccine candidate as several participants in the early-stage trials generated antibodies for HIV after receiving the potential therapeutic.
There were no serious adverse events or safety concerns reported in the 216 participants of the phase 1 trial of the v451 COVID-19 vaccine candidate being developed by the University of Queensland (UQ) in collaboration with biotech company CSL, according to a statement.
However, data showed that some patients developed antibodies towards fragments of a HIV protein (gp41), which was used to stabilise the vaccine, it said.
Following consultation with the Australian Government, UQ and CSL decided not to progress the vaccine candidate to phase 2 and 3 clinical trials.
The vaccine was one of four candidates that Australia had committed to buy and accordingly agreements were made to secure 51 million doses of the experimental vaccine.
UQ said the trial participants were fully informed of the possibility of a partial immune response to this protein component, however, it was unexpected that the antibody levels induced would interfere with certain HIV tests.
The university said there is no possibility the vaccine causes infection, and routine follow up tests confirmed there is no HIV virus present.
Conclusions
We provide short summary and some exam notes of all subjects and for all classes.this notes is related to class 12th commerce/arts indian economy notes.In our page we learn all classes subjects and different knowledge.our youtube channel also available so you get for information go to channel.now we work on application for all classes and easy way to get notes and pdf of exam idea so you ready to learn from our easy adda.
We belongs to araria bihar.behind this website hands of Bhola and Nadeem.we both belongs to Jnv.you can learn also from my youtube channel.youtube channel is "Easy Adda".
ConversionConversion EmoticonEmoticon